How to Source Drotaverine + Mefenamic Acid Tablet for Pharmaceutical Formulation
Drotaverine + Mefenamic Acid Tablet (Tablets, 80mg + 250mg) is classified under Analgesic. It is therapeutically aligned with reference brands such as Dovenrin-M, Drotikind-M. This guide highlights key sourcing factors buyers should consider when procuring high-quality Drotaverine + Mefenamic Acid Tablet for formulation, R&D, or bulk manufacturing.
Product Overview:
Drotaverine+Mefenamic acid is used to treat menstrual cramps, stomach pain and muscle spasms. This combination may also be useful in pain due to bowel disorders, after surgery and due to kidney stones.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Drotaverine + Mefenamic Acid Tablet must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Drotaverine + Mefenamic Acid Tablet is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Drotaverine + Mefenamic Acid Tablet is more than procurement—it’s a strategic partnership. With its tablets form and 80mg + 250mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Drotaverine + Mefenamic Acid Tablet.
Frequently Asked Questions For Sourcing of Drotaverine + Mefenamic Acid Tablet
What is the typical lead time for Drotaverine + Mefenamic Acid Tablet?
Lead times range from 4–6 weeks depending on supplier and region.
Is Drotaverine + Mefenamic Acid Tablet available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Drotaverine + Mefenamic Acid Tablet require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Drotaverine + Mefenamic Acid Tablet?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Drotaverine + Mefenamic Acid Tablet?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Drotaverine + Mefenamic Acid Tablet?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Drotaverine + Mefenamic Acid Tablet suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Drotaverine + Mefenamic Acid Tablet be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
Advertise on PharmaTradZ
Reach verified pharma buyers, suppliers & decision makers worldwide.
Explore Pharma Investment Opportunities
Connect with partners, startups & ventures driving the future of pharma.